健麾信息(605186) - 投资者关系活动记录表

Group 1: Market Performance and Technical Advantages - The company is recognized as a leading provider of pharmaceutical logistics automation, information technology, and mobile healthcare solutions, with significant advantages in software and hardware system integration, data processing, equipment management, automated dispensing, and robotics technology [1] - The company plans to enhance R&D investment to meet the growing demands of the overseas market and drive product innovation and technological upgrades [1] Group 2: Dividend Policy and Shareholder Returns - For the fiscal year 2023, the company plans to distribute a cash dividend of 1.00 yuan (tax included) for every 10 shares, totaling 13,600,000.00 yuan (tax included), which represents 22.67% of the net profit attributable to shareholders [2] - The company aims to establish a robust shareholder return mechanism to protect the rights of minority shareholders and create stable return expectations [2] Group 3: Industry Policy Trends - The healthcare sector is experiencing significant impacts from policy reforms, with a focus on promoting high-quality development in public hospitals, which is expected to enhance market conditions [2] - The company will actively respond to the policy environment, adjust its business strategies, strengthen product R&D, expand overseas markets, and optimize production and management efficiency [2]